|
Market Closed -
Nasdaq Stockholm
08:30:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.0501 SEK | +13.86% |
|
-30.42% | -77.93% |
| 10-29 | Stockholm Stock Exchange closed higher after choppy opening | FW |
| 10-29 | Stockholm shares trade unevenly at midday, sharp declines for Bioinvent and Immunovia | FW |
Company Valuation: Immunovia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,697 | 595.2 | 92.66 | 152.7 | 33.7 | - | - |
| Change | - | -64.93% | - | 64.79% | -77.93% | - | - |
| Enterprise Value (EV) 1 | 1,443 | 526.7 | 92.66 | 76.09 | -1.299 | 3.701 | -21.3 |
| Change | - | -63.5% | - | -17.88% | -101.71% | 384.8% | -675.56% |
| P/E | -0.11x | -0.04x | -0.01x | -0.54x | -0.5x | -1.25x | -2.51x |
| PBR | 0.04x | 0.02x | - | - | - | - | - |
| PEG | - | -0.01x | - | 0x | 0x | 0x | 0.1x |
| Capitalization / Revenue | 1,775x | 494x | - | 203x | 10.5x | 1.95x | 0.61x |
| EV / Revenue | 1,510x | 437x | - | 101x | -0.41x | 0.21x | -0.39x |
| EV / EBITDA | -9.78x | -3.17x | - | -0.97x | 0.02x | -0.05x | 0.51x |
| EV / EBIT | -8.66x | -2.76x | - | -0.95x | 0.01x | -0.05x | 0.47x |
| EV / FCF | -9.27x | -2.97x | - | -0.91x | 0.01x | -0.05x | 0.43x |
| FCF Yield | -10.8% | -33.6% | - | -110% | 6,695% | -2,162% | 235% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -689 | -743 | -93 | -0.42 | -0.1 | -0.04 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.956 | 1.204 | - | 0.752 | 3.2 | 17.3 | 55 |
| EBITDA 1 | -147.6 | -166.2 | - | -78.06 | -85 | -74 | -42 |
| EBIT 1 | -166.6 | -191.2 | - | -80.38 | -88 | -76 | -45 |
| Net income 1 | -156 | -168.1 | -76.54 | -145.9 | -87 | -76 | -45 |
| Net Debt 1 | -254.1 | -68.47 | - | -76.6 | -35 | -30 | -55 |
| Reference price 2 | 75.0000 | 26.3000 | 0.5460 | 0.2270 | 0.0501 | 0.0501 | 0.0501 |
| Nbr of stocks (in thousands) | 22,632 | 22,632 | 169,711 | 672,667 | 672,667 | - | - |
| Announcement Date | 2/17/22 | 2/23/23 | 2/25/25 | 2/24/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.5x | -0.41x | 0.02x | - | 3.43M | |
| 35.69x | 6.07x | 23.2x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 35.93x | 6.43x | 19.03x | 0.43% | 88.35B | |
| Weighted average by Cap. | 39.12x | 7.39x | 22.11x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMMNOV Stock
- Valuation Immunovia AB
Select your edition
All financial news and data tailored to specific country editions
